In a recent breakthrough, Masimo Corporation MASI announced that its Next Generation SedLine brain function monitoring has received clearance from the FDA. The device will provide clinicians real-time ...
Masimo (NASDAQ: MASI) announced today that it has received CE Mark for its SEDLine brain function monitor - expanding access to and availability of SEDLine's advanced neuromonitoring technology to ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the FDA clearance of SedLine ® brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback